v3.25.2
SUMMARY OF STOCK OPTIONS (Details)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2025
$ / shares
shares
Mar. 31, 2025
$ / shares
shares
Mar. 31, 2024
$ / shares
shares
Mar. 31, 2024
$ / shares
shares
Jun. 30, 2025
shares
Sep. 30, 2025
shares
Sep. 30, 2024
shares
Mar. 31, 2025
$ / shares
shares
Mar. 31, 2025
$ / shares
shares
Mar. 31, 2024
$ / shares
shares
Mar. 31, 2024
$ / shares
shares
Share-Based Payment Arrangement [Abstract]                      
Number of stock options, Outstanding beginning balance               542,334 542,334 258,516 258,516
Weighted- Average Exercise Price, Outstanding beginning balance | (per share)               $ 22.32 [1] $ 32.09 $ 15.08 [1] $ 21.68
Number of stock options, Granted 158,235 158,235 70,925 70,925 4,592,428 3,913,694 6,518,044 364,099 364,099 370,365 370,365
Weighted- Average Exercise Price, Granted | (per share)               $ 19.05 [1] $ 27.39 $ 25.41 [1] $ 36.53
Number of stock options, Exercised               (51,235) (51,235) (86,547) (86,547)
Weighted- Average Exercise Price, Exercised | (per share)               $ 16.15 [1] $ 23.22 $ 13.87 [1] $ 19.94
Number of stock options, Cancelled               (84,314) (84,314)    
Weighted- Average Exercise Price, Cancelled | (per share)               $ 24.60 [1] $ 35.37    
Number of stock options, Outstanding ending balance 770,884 770,884 542,334 542,334       770,884 770,884 542,334 542,334
Weighted- Average Exercise Price, Outstanding ending balance | (per share) $ 20.94 [1] $ 30.10 $ 22.32 [1] $ 32.09       $ 20.94 [1] $ 30.10 $ 22.32 [1] $ 32.09
Number of stock options, Exercisable ending balance 511,487 511,487           511,487 511,487    
Weighted- Average Exercise Price, Exercisable ending balance | (per share) $ 20.81 [1] $ 29.92           $ 20.81 [1] $ 29.92    
[1] Converted at balance sheet rate.